Profile data is unavailable for this security.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shanghai Junshi Biosciences Co Ltd | 2.48bn | -949.86m | 28.77bn | 2.67k | -- | 5.26 | -- | 11.59 | -0.96 | -0.96 | 2.51 | 6.05 | 0.2203 | 0.8436 | 5.48 | 963,148.80 | -9.45 | -17.61 | -12.31 | -22.00 | 81.59 | 68.46 | -42.92 | -84.56 | 1.43 | -23.04 | 0.3629 | -- | 29.67 | 20.24 | 43.90 | -- | -4.33 | -- |
| Xiamen Amoytop Biotech Co Ltd | 3.34bn | 939.58m | 30.11bn | 2.42k | 31.94 | 9.97 | -- | 9.01 | 2.31 | 2.31 | 8.22 | 7.40 | 1.03 | 0.8127 | 4.99 | 1,379,284.00 | 29.05 | 22.72 | 33.93 | 26.54 | 92.37 | 91.62 | 28.11 | 23.51 | 3.20 | -- | 0.0448 | 28.80 | 34.13 | 31.02 | 49.00 | 66.70 | 41.17 | 90.06 |
| Beijing Tiantan Biological Products Corp | 6.42bn | 1.32bn | 32.39bn | 5.30k | 24.61 | 2.83 | -- | 5.04 | 0.6656 | 0.6656 | 3.25 | 5.80 | 0.4002 | 0.9382 | 11.21 | 1,212,453.00 | 11.25 | 11.93 | 16.06 | 16.79 | 45.65 | 50.69 | 28.10 | 29.69 | 3.08 | -- | 0.0152 | 16.24 | 16.44 | 12.94 | 39.58 | 20.45 | 15.19 | 23.56 |
| Humanwell Healthcare Group Co Ltd | 24.18bn | 1.43bn | 32.64bn | 17.65k | 22.88 | 1.73 | -- | 1.35 | 0.8741 | 0.8741 | 14.84 | 11.59 | 0.6519 | 3.63 | 2.48 | 1,369,715.00 | 5.00 | 6.40 | 8.73 | 12.55 | 44.53 | 43.83 | 7.67 | 9.90 | 1.40 | 362.14 | 0.2889 | 25.97 | 3.71 | 3.13 | -37.70 | 11.15 | 4.75 | 56.54 |
| Sunshine Guojian Pharmcutcl Shngh Co Ltd | 1.37bn | 870.39m | 35.81bn | 995.00 | 41.33 | 6.06 | -- | 26.13 | 1.40 | 1.40 | 2.21 | 9.56 | 0.186 | 1.54 | 4.55 | 1,377,045.00 | 11.66 | 3.14 | 15.35 | 3.34 | 74.88 | 77.37 | 62.65 | 16.95 | 1.97 | -- | 0.00 | 12.57 | 17.70 | 0.2733 | 139.15 | 25.17 | 16.61 | -- |
| Bluestar Adisseo Co | 17.09bn | 1.19bn | 35.91bn | 2.93k | 26.22 | 1.85 | -- | 2.10 | 0.4447 | 0.4447 | 6.37 | 6.31 | 0.7204 | 5.30 | 8.18 | 5,834,541.00 | 5.03 | 5.20 | 6.05 | 6.63 | 27.69 | 29.69 | 6.99 | 8.12 | 1.12 | 10.31 | 0.1377 | 30.01 | 17.83 | 6.88 | 2,208.66 | 3.95 | 5.53 | -7.02 |
| Gan & Lee Pharmaceuticals | 3.85bn | 925.74m | 38.52bn | 5.25k | 41.13 | 3.42 | -- | 10.01 | 1.57 | 1.57 | 6.54 | 18.88 | 0.3158 | 0.9071 | 9.73 | 733,533.10 | 7.60 | 6.19 | 8.10 | 6.58 | 74.62 | 81.80 | 24.06 | 22.31 | 5.57 | -- | 0.001 | 44.12 | 16.77 | 1.02 | 80.75 | -12.04 | 1.63 | -- |
| Guangzhou Baiyunshan Phrmcl Hldgs Co Ltd | 77.54bn | 2.99bn | 39.35bn | 28.14k | 13.83 | 1.09 | -- | 0.5075 | 1.84 | 1.84 | 47.69 | 23.32 | 0.9548 | 5.79 | 4.33 | 2,755,662.00 | 3.83 | 5.33 | 7.36 | 10.95 | 16.23 | 18.07 | 4.01 | 5.28 | 1.31 | -- | 0.2873 | 28.87 | -0.692 | 2.92 | -30.09 | -2.32 | -14.01 | 6.32 |
| Beijing Tong Ren Tang Co Ltd | 18.09bn | 1.35bn | 41.67bn | 17.88k | 30.78 | 3.05 | -- | 2.30 | 0.9871 | 0.9871 | 13.19 | 9.96 | 0.5736 | 0.9376 | 11.40 | 1,011,323.00 | 5.99 | 8.13 | 11.72 | 15.95 | 43.19 | 46.02 | 10.45 | 13.34 | 1.89 | -- | 0.1629 | 33.28 | 4.12 | 6.97 | -8.54 | 9.14 | 2.30 | 5.64 |
Data as of Mar 03 2026. Currency figures normalised to Gan & Lee Pharmaceuticals's reporting currency: Chinese Yuan Renminbi CNY
7.42%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| China Southern Asset Management Co., Ltd.as of 30 Jun 2025 | 12.81m | 2.41% |
| China Merchants Fund Management Co., Ltd.as of 30 Jun 2025 | 6.23m | 1.17% |
| Yinhua Fund Management Co., Ltd.as of 30 Jun 2025 | 3.51m | 0.66% |
| Changsheng Fund Management Co., Ltd.as of 30 Jun 2025 | 3.34m | 0.63% |
| Tian Hong Asset Management Co., Ltd.as of 30 Jun 2025 | 3.18m | 0.60% |
| GF Fund Management Co., Ltd.as of 30 Jun 2025 | 2.48m | 0.47% |
| Penghua Fund Management Co., Ltd.as of 30 Jun 2025 | 2.30m | 0.43% |
| China Universal Asset Management Co., Ltd.as of 30 Jun 2025 | 2.02m | 0.38% |
| Guotai Asset Management Co., Ltd.as of 30 Jun 2025 | 2.00m | 0.38% |
| The Vanguard Group, Inc.as of 31 Jan 2026 | 1.54m | 0.29% |
More ▼
Data from 30 Jun 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
